Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients

Annals of Pharmacotherapy

Volumn 44, Issue 1, 2010, Pages 19-27

  Al Khatib, Mai ^f   Shapiro, R Jean ^a,b   Partovi, Nilufar ^b,c   Ting, Lillian S L ^d   Levine, Marc ^b   Ensom, Mary H H ^b,e  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d NOVARTIS PHARMA AG   (Switzerland)

^e CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^f NONE

Author keywords

Islet transplant; Limited sampling strategy; Mycophenolic acid; Therapeutic drug monitoring

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; GRAFT RECIPIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OPEN STUDY; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; SAMPLING;

ADULT; AGED; AREA UNDER CURVE; BLOOD SPECIMEN COLLECTION; DRUG MONITORING; ENZYME INHIBITORS; FEMALE; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 74549172888     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M511     Document Type: Article

References (33)

1. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007;46:13-58.
2. Knight SR, Morris PJ. Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review. Transplantation 2008;85:1675-85.
3. Shaw LM, Korecka M, Venkataramanan R, Goldberg L, Bloom R, Brayman KL. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 2003;3:534-42.
4. Johnson AG, Rigby RJ, Taylor PJ, et al. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients. Clin Pharmacol Ther 1999;66:492-500.
5. Yeung S, Tong KL, Tsang WK, et al. Determination of mycophenolate area under the curve by limited sampling strategy. Transplant Proc 2001;33:1052-3.
6. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 2002;48:1497-504.
7. Le Guellec C, Büchler M, Giraudeau B, et al. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol 2002;57:805-11.
8. Cho EK, Han DJ, Kim SC, Burckart GJ, Venkataramanan R, Oh JM. Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients. J Clin Pharmacol 2004;44:743-50.
9. van Hest RM, Mathôt RAA, Vulto AG, Le Meur Y, van Gelder T. Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy. Ther Drug Monit 2004;26:620-5.
10. Fleming DH, Mathew BS, John GT, Chandy SJ, Manivannan J, Jeyaseelan V. A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent. J Postgrad Med 2006;52:248-52.
11. Zicheng Y, Peijun Z, Da X, Xianghui W, Hongzhuan C. Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients. Br J Clin Pharmacol 2006;62:446-52.
12. Zhou PJ, Yu ZC, Wang XH, Shao K, Zhao JP. Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients. Clin Pharmacokinet 2007;46:389-401.
13. Jiao Z, Zhong J, Zhang M, Shi X, Yu Y, Lu W. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies. Eur J Clin Pharmacol 2007;63:27-37.
14. Miura M, Satoh S, Niioka T, et al. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients. Ther Drug Monit 2008;30:52-9.
15. Mohammadpour AH, Nazemian F, Abtahi B, et al. Estimation of abbreviated mycophenolic acid area under the concentration-time curve during early posttransplant period by limited sampling strategy. Transplant Proc 2008;40:3668-72.
16. Muller H, Solari S, Zuniga C, et al. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: an abbreviated sampling strategy. Transplant Proc 2007;39:596-9.
17. Figurski MJ, Nawrocki A, Pescovitz MD, Bouw R, Shaw LM. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine. Ther Drug Monit 2008;30:445-55.
18. Chen H, Gu Z, Chen B, Mao H, Zhang W, Fan Q. Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in Chinese patients undergoing liver transplantation. Clin Ther 2008;30:2387- 401.
19. Ting LS, Partovi N, Levy RD, Ignaszewski AP, Ensom MH. Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients. J Heart Lung Transplant 2008;27:325-8.
20. Ting LSL, Partovi N, Levy RD, et al. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and acyl glucuronide metabolites in stable thoracic transplant recipients. Ther Drug Monit 2008;30:282-91.
21. Ting LSL, Villeneuve E, Ensom MHH. Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants. Ther Drug Monit 2006;28:419-30.
22. Prémaud A, Le Meur Y, Debord J, et al. Maximum a posteriori Bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods. Ther Drug Monit 2005;27:354-61.
23. Gaston RS, Kaplan B, Shah T, et al. Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant 2009;9:1607-19.
24. van Gelder T, Silva HT, de Fijter JW, et al. Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation 2008;86:1043-51.
25. van Gelder T. Mycophenolate blood level monitoring: recent progress. Am J Transplant 2009;9:1495-9.
26. Oremus M, Zeidler J, Ensom MHH, et al. Utility of monitoring mycophenolic acid in solid organ transplant patients. Evid Rep Technol Assess 2008;164:1-131.
27. Bruchet NK, Ensom MHH. Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review. Expert Opin Drug Metab Toxicol 2009;5:1079-97.
28. van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit 2001;23:119-28.
29. Cox VC, Ensom MHH. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring? Ther Drug Monit 2003;25:137-57.
30. Ting LSL, Partovi N, Levy RD, Riggs KW, Ensom MHH. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients. Pharmacotherapy 2006;26:1232-40.
31. Kaczmarek I, Bigdeli AK, Vogeser M, et al. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients. Ther Drug Monit 2008;30:419-27.
32. Bullingham R, Shah J, Goldblum R, Schiff M. Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients. Br J Clin Pharmacol 1996;41:513-6.
33. Le Meur Y, Büchler M, Thierry A, et al. Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant 2007;11:2496-503.